As part of the European Union, the UK was a stronghold of anti-GMO opposition. Post-Brexit, however, Britain is changing its outlook for the better. After more than a year of intense public debate, the country'sDepartment for Environment, Food & Rural Affairs (DEFRA) recently announced less restrictive rules that will help the UK's biotech sector develop gene-edited crops designed to boost sustainable farming:

The rule changes, made possible by the UKs departure from the EU, will mean that scientists across England will be able to undertake plant-based research and development, using genetic technologies such as gene editing, more easily.

The rules will apply to plants where gene editing is used to create new varieties similar to those which could have been produced more slowly through traditional breeding processes and will unlock research opportunities to grow crops which are more nutritious, and which require less pesticide use.

This is a tremendous step in the right direction for a country that has denied farmers the benefits of crop biotechnology for decades. Conspicuously missing from DEFRA's announcement, though, was any reference to transgenic crops, the wrongly maligned "GMOs" we're all familiar with. [1] While transgenic technology could benefit UK farmers and consumers, as it has in dozens of other countries, regulators remain unwilling to take on the politically charged fight that would precede the reformation of Britain's GMO regulations, at least for now.

In the spirit of hastening the UK's acceptance of all crop biotechnology, I recently partnered with the London-based Adam Smith Institute to produce a new report titled Splice of Life: The case for GMOs and gene editing. In it, I survey more than two decades' worth of research documenting the benefits of growing and consuming GMOs. The key takeaways are as follows:

How could the UK so liberate its biotech industry? I argue that the ideal regulatory framework is a case-by-case risk assessment that evaluates each novel organism based on the harms it may pose to humans and the environment, regardless of which breeding method produced it. The organisms characteristics and intended use would determine the degree of scrutiny applied by regulators.

Matt Ridley, legendary science writer and member of the UK's House of Lords, had this to say about Splice of Life:

The governments sluggishness in embracing gene engineering is disappointing. This technology, in which Britain could be world-leading, provides immense benefits to farmers, consumers and the environment. Yet, as this important new report from the Adam Smith Institute highlights, gene editing will be severely hampered and GMOs will be left behind. Scientific evidence, not activist superstition, should be at the centre of policy making.

[1] For the record, "GMO" is a nonsense term no scientist uses in a professional context. Nearly all food crops we consume were the products of traditional plant breeding, which "genetically modified" them in all sorts of ways. Transgenic plants are not unique in this respect.

Read this article:
World Tour: ACSH Makes The Case For GMOs In The UK - American Council on Science and Health